SciELO - Scientific Electronic Library Online

 
vol.82 issue3Cell therapy for ischemic heart diseaseCurrent status of cardiac resynchronization therapy author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

VALERO, Elina  and  PESCE, Ricardo. Totally subcutaneous defibrillator. Arch. Cardiol. Méx. [online]. 2012, vol.82, n.3, pp.230-234. ISSN 1665-1731.

The implantable cardioverter-defibrillators (ICD) is a therapy for the prevention of sudden cardiac death. Complications with implant have been associated mainly with transvenous lead insertion. Difficulties in achieving venous access can occasionally result in failed ICD implantation. Lead failures remains a major limitation and often require removal. This procedure is associated with important morbidity and mortality. To eliminate the need for venous access, Bardy et al. designed an entirely subcutaneous ICD system. The subcutaneous ICD consists of a 3-mm tripolar parasternal electrode positioned parallel to the left of the sternal midline and guided exclusively by anatomical landmarks without fluoroscopy. The pulse generator is positioned over the sixth rib between the midaxillary line and the anterior axillary line. The device delivers a maximum of only 80-J shocks. Ventricular fibrillation was converted twice in 58 of 59 patients (98%) with the delivery of 65-J shocks in two tests to ensure a margin of safety. A demand pacing at 50 beats per minute is available for 30 seconds after a shock. These studies are preliminary but the system will need to be employ in a long-term, randomized, prospective, multicenter clinical trials.

Keywords : Cardiodefibrillator; Subcutaneous implantation; Argentina.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License